New trends in the treatment of osteogenesis imperfecta type III – own experience

Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2008, Vol 10, Issue 6

Abstract

Introduction: Osteogenesis imperfecta (OI) is a genetic disorder caused by a mutation in the genes that encode the chains of type I collagen. Clinical manifestations include increased bone fragility and blue sclerae. OI type III is the most severe form with fractures occurring already in utero. Fracture immobilisation and orthopaedic surgery are the mainstay of treatment for patients with OI, and are combined with rehabilitation and bisphosphonate therapy.Patients and methods: The study involved 8 children with osteogenesis imperfecta type III, aged 1 month to 6 years. All of them were treated with cyclic intravenous infusions of pamidronate. Laboratory studies conducted before and after each 3-day cycle of pamidronate therapy included complete blood count, serum calcium, phosphorus, magnesium, osteocalcin, and calcium/creatinine index in morning urine and collagen type I cross-linked N-telopeptide (NTx). Infant total body densitometric scans were obtained in 5/8 patients.Results: Patients were treated for periods of 3-58 months. Fracture rates decreased with treatment in all patients compared to the prenatal period. Pamidronate also slowed down bone turnover, and particularly the resorption rate. The most common side effects during treatment included hypocalcaemia (7/8 patients) and fever (up to 39°C) after the first cycle of treatment.Conclusion: Symptomatic bisphosphonate therapy in children with osteogenesis imperfecta ameliorated the clinical course (decreased bone pain and reduced incidence of fractures). Pamidronate therapy had a positive impact on functional parameters such as independence in everyday activities and better mobility. The treatment was safe.

Authors and Affiliations

Elżbieta Jakubowska-Pietkiewicz , Danuta Chlebna-Sokół

Keywords

Related Articles

Posture in people with shoulder impingement syndrome

Introduction. The posture of people with shoulder impingement syndrome (SIS) is a result of adaptive defensive posturing to decrease the intensity of pain in the affected joint. The aim of this work is to characterise tr...

<br /> Pierwsze doświadczenia w implantacji trzpienia przynasadowego Metha <br />

Wstęp. Jednym z nowszych sposobów leczenia choroby zwyrodnieniowej stawu biodrowego u młodych chorych jest alloplastyka z użyciem trzpieni przynasadowych. Jego zaletą w porównaniu do trzpieni tradycyjnych jest bardziej f...

Outcome in the arthroscopic treatment of synovial chondromatosis of the knee

Background. Synovial osteochondromatosis is a disease in which loose cartilaginous bodies develop around large joints, usually the knee. It is caused by synovial metaplasia of unknown etiology. Symptoms are due either to...

Romuald Węgłowski (1876-1935) – Orthopaedic Surgeon, Forgotten Pioneer of Limb Saving Tumour Surgery

On May 16, 1914, The Lancet Journal published a paper by Romuald Węgłowski, a Polish-born professor of Moscow University, entitled „Malignant tumours of bones: a new method in conservative operative treatment.” The idea...

Ocena zmian kifozy piersiowej i lordozy lędźwiowej w trakcie leczenia operacyjnego skoliozy idiopatycznej metodą Cotrel-Duboussete'a

Wstęp. Korekcja kifozy piersiowej i lordozy lędźwiowej podczas operacyjnego leczenia skolioz metodą C-D jest kontrowersyjną i dyskutowaną przez wielu autorów.Materiał i metody. Analizie poddane zostały boczne radiogramy...

Download PDF file
  • EP ID EP56861
  • DOI -
  • Views 113
  • Downloads 0

How To Cite

Elżbieta Jakubowska-Pietkiewicz, Danuta Chlebna-Sokół (2008). New trends in the treatment of osteogenesis imperfecta type III – own experience. Ortopedia Traumatologia Rehabilitacja, 10(6), 593-601. https://europub.co.uk./articles/-A-56861